Atrial fibrillation (AF) significantly increases the risk of stroke. About 40% of people with AF show no symptoms, which means many are only diagnosed by chance, often when they are hospitalized for something else, including a stroke. According to extensive studies, the timely initiation of therapy upon detecting atrial fibrillation can substantially diminish the risk of stroke by an impressive 68%. 

Prolife AFIB technology detects atrial fibrillation, a silent yet dangerous heart condition, within multiple pumping cycles during a single measurement, depending on the patient's characteristics. Should the AF indicator illuminate on the display, it is imperative to conduct an additional measurement and for instance repeat the process after one hour. Should the AF symbol reappear, prompt consultation with a medical expert is strongly advised.